Expression and clinical significance of cyclooxygenase‑2 and interleukin‑32 in primary gastric B‑cell lymphoma

  • Authors:
    • Yingying Cui
    • Zhenchang Sun
    • Xin Li
    • Changsen Leng
    • Lei Zhang
    • Xiaorui Fu
    • Ling Li
    • Xudong Zhang
    • Yu Chang
    • Feifei Nan
    • Zhaoming Li
    • Jiaqin Yan
    • Mingzhi Zhang
    • Wencai Li
    • Guannan Wang
    • Dandan Zhang
    • Yaozhen Ma
  • View Affiliations

  • Published online on: November 20, 2015     https://doi.org/10.3892/ol.2015.3950
  • Pages: 693-698
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cyclooxygenase‑2 (COX‑2) and interleukin‑32 (IL‑32) expression has been examined in various carcinomas and inflammations, and has been suggested to be significant in tumor progression and prognosis. The present study was conducted to investigate the expression of COX‑2 and IL‑32 in primary gastric B‑cell lymphoma in order to define their clinical significance and their association with Helicobacter pylori (Hp) infection. COX‑2 and IL‑32 protein expression was detected in 31 primary gastric B‑cell lymphoma patients and 19 chronic gastritis patients with immunohistochemistry. COX‑2 and IL‑32 expression was significantly higher in primary gastric lymphoma (PGL) tissues compared with gastritis tissues (51.6 vs. 21.1% for COX‑2, P=0.032; and 58.1 vs. 26.3% for IL‑32, P=0.029) and was significantly higher in Hp+ lymphoma tissues compared with Hp‑ lymphoma tissues (66.7 vs. 20% for COX‑2, P=0.015; and 71.4 vs. 30% for IL‑32, P=0.029). In the PGL tissues, the expression level of COX‑2 was positively correlated with the expression level of IL‑32, and the two were each positively correlated with Hp infection (P=0.004 for COX‑2 and IL‑32; P=0.01 for COX‑2 and Hp infection; and P=0.003 for IL‑32 and Hp infection). COX‑2 expression was found to be significantly associated (P<0.05) with an aggressive tumor type, higher expression of Ki‑67, frequent lymph node metastasis and advanced stage. IL‑32 expression was found to be significantly correlated (P<0.05) with frequent lymph node metastasis and an advanced stage. The survival time was longer in the COX‑2‑ and IL‑32‑ lymphoma patients compared with the COX‑2+ and IL‑32+ lymphoma patients, but these differences were not statistically significant. These results suggested that Hp infection and the expression of COX‑2 and IL‑32 were closely linked with each other, and that the overexpression of COX‑2 and IL‑32 was correlated with tumor progression in primary gastric B‑cell lymphoma, thus indicating potential novel therapeutic target.
View Figures
View References

Related Articles

Journal Cover

January-2016
Volume 11 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cui Y, Sun Z, Li X, Leng C, Zhang L, Fu X, Li L, Zhang X, Chang Y, Nan F, Nan F, et al: Expression and clinical significance of cyclooxygenase‑2 and interleukin‑32 in primary gastric B‑cell lymphoma. Oncol Lett 11: 693-698, 2016
APA
Cui, Y., Sun, Z., Li, X., Leng, C., Zhang, L., Fu, X. ... Ma, Y. (2016). Expression and clinical significance of cyclooxygenase‑2 and interleukin‑32 in primary gastric B‑cell lymphoma. Oncology Letters, 11, 693-698. https://doi.org/10.3892/ol.2015.3950
MLA
Cui, Y., Sun, Z., Li, X., Leng, C., Zhang, L., Fu, X., Li, L., Zhang, X., Chang, Y., Nan, F., Li, Z., Yan, J., Zhang, M., Li, W., Wang, G., Zhang, D., Ma, Y."Expression and clinical significance of cyclooxygenase‑2 and interleukin‑32 in primary gastric B‑cell lymphoma". Oncology Letters 11.1 (2016): 693-698.
Chicago
Cui, Y., Sun, Z., Li, X., Leng, C., Zhang, L., Fu, X., Li, L., Zhang, X., Chang, Y., Nan, F., Li, Z., Yan, J., Zhang, M., Li, W., Wang, G., Zhang, D., Ma, Y."Expression and clinical significance of cyclooxygenase‑2 and interleukin‑32 in primary gastric B‑cell lymphoma". Oncology Letters 11, no. 1 (2016): 693-698. https://doi.org/10.3892/ol.2015.3950